Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees
- PMID: 21252247
- PMCID: PMC3100671
- DOI: 10.1210/jc.2010-1906
Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees
Abstract
Context and objective: Recessive mutations in the hydroxyacyl-CoA dehydrogenase (HADH) gene encoding the enzyme 3-hydroxyacyl-CoA dehydrogenase are a rare cause of diazoxide-responsive hyperinsulinemic hypoglycemia (HH) with just five probands reported to date. HADH deficiency in the first three identified patients was associated with detectable urinary 3-hydroxyglutarate and raised plasma 3-hydroxybutyryl-carnitine levels, but two recent cases did not have abnormal urine organic acids or acylcarnitines.
Research design and methods: We studied 115 patients with diazoxide-responsive HH in whom the common genetic causes of HH had been excluded. No patients were reported to have abnormal acylcarnitines or urinary organic acids. Homozygosity mapping was undertaken in probands from 13 consanguineous pedigrees to search for regions harboring mutations that are identical by descent.
Results: HADH sequencing was performed after genome-wide single nucleotide polymorphism analysis revealed a large shared region of homozygosity spanning the HADH locus in six unrelated probands. Homozygous mutations were identified in three of these patients and in a further two probands from consanguineous families. HADH analysis in the remainder of the cohort identified mutations in a further six probands for whom consanguinity was not reported, but who originated from countries with high rates of consanguinity. Six different HADH mutations were identified in 11/115 (10%) patients tested.
Conclusion: HADH mutations are a relatively common cause of diazoxide-responsive HH with a frequency similar to that of GLUD1 and HNF4A mutations. We recommend that HADH sequence analysis is considered in all patients with diazoxide-responsive HH when recessive inheritance is suspected.
Figures
![Fig. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3100671/bin/zeg0031179260001.gif)
Comment in
-
Nesidioblastosis no longer! It's all about genetics.J Clin Endocrinol Metab. 2011 Mar;96(3):617-9. doi: 10.1210/jc.2011-0164. J Clin Endocrinol Metab. 2011. PMID: 21378225 No abstract available.
Similar articles
-
3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyperinsulinemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity.J Clin Endocrinol Metab. 2009 Jul;94(7):2221-5. doi: 10.1210/jc.2009-0423. Epub 2009 May 5. J Clin Endocrinol Metab. 2009. PMID: 19417036 Free PMC article.
-
Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations.Eur J Endocrinol. 2010 May;162(5):987-92. doi: 10.1530/EJE-09-0861. Epub 2010 Feb 17. Eur J Endocrinol. 2010. PMID: 20164212 Free PMC article.
-
Protein-induced hyperinsulinaemic hypoglycaemia due to a homozygous HADH mutation in three siblings of a Saudi family.J Pediatr Endocrinol Metab. 2015 Sep;28(9-10):1073-7. doi: 10.1515/jpem-2015-0033. J Pediatr Endocrinol Metab. 2015. PMID: 25915078
-
Congenital hyperinsulinism due to mutations in HNF4A and HADH.Rev Endocr Metab Disord. 2010 Sep;11(3):185-91. doi: 10.1007/s11154-010-9148-y. Rev Endocr Metab Disord. 2010. PMID: 20931292 Review.
-
Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenase.J Clin Endocrinol Metab. 2013 Feb;98(2):496-501. doi: 10.1210/jc.2012-3134. Epub 2012 Dec 18. J Clin Endocrinol Metab. 2013. PMID: 23253615 Review.
Cited by
-
Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2 or its regulatory elements.Eur J Hum Genet. 2024 Jul;32(7):813-818. doi: 10.1038/s41431-024-01593-z. Epub 2024 Apr 11. Eur J Hum Genet. 2024. PMID: 38605124 Free PMC article.
-
The Physiological and Pathological Role of Acyl-CoA Oxidation.Int J Mol Sci. 2023 Oct 3;24(19):14857. doi: 10.3390/ijms241914857. Int J Mol Sci. 2023. PMID: 37834305 Free PMC article. Review.
-
Congenital Hyperinsulinism: Current Laboratory-Based Approaches to the Genetic Diagnosis of a Heterogeneous Disease.Front Endocrinol (Lausanne). 2022 Jul 7;13:873254. doi: 10.3389/fendo.2022.873254. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35872984 Free PMC article. Review.
-
Investigating Genetic Mutations in a Large Cohort of Iranian Patients with Congenital Hyperinsulinism.J Clin Res Pediatr Endocrinol. 2022 Mar 3;14(1):87-95. doi: 10.4274/jcrpe.galenos.2021.2021.0071. Epub 2021 Dec 20. J Clin Res Pediatr Endocrinol. 2022. PMID: 34927408 Free PMC article.
-
Genetic pathogenesis, diagnosis, and treatment of short-chain 3-hydroxyacyl-coenzyme A dehydrogenase hyperinsulinism.Orphanet J Rare Dis. 2021 Nov 4;16(1):467. doi: 10.1186/s13023-021-02088-6. Orphanet J Rare Dis. 2021. PMID: 34736508 Free PMC article. Review.
References
-
- Kapoor RR, Flanagan SE, James C, Shield J, Ellard S, Hussain K. 2009. Hyperinsulinaemic hypoglycaemia. Arch Dis Child 94:450–457 - PubMed
-
- Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M. 1998. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352–1357 - PubMed
-
- Otonkoski T, Jiao H, Kaminen-Ahola N, Tapia-Paez I, Ullah MS, Parton LE, Schuit F, Quintens R, Sipila I, Mayatepek E, Meissner T, Halestrap AP, Rutter GA, Kere J. 2007. Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. Am J Hum Genet 81:467–474 - PMC - PubMed
-
- Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE. 2001. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest 108:457–465 - PMC - PubMed
-
- Molven A, Matre GE, Duran M, Wanders RJ, Rishaug U, Njolstad PR, Jellum E, Sovik O. 2004. Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes 53:221–227 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous